This week's life sciences industry news includes a Main Line firm's new development in its pursuit of a drug for Parkinson's and Alzheimer's diseases, a Wilmington company's drug approval in the United Kingdom, a firm with Philadelphia operations divesting a business unit to a Swiss company, and more.
